Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -27.50M | -24.62M | -25.29M | -28.48M | -28.17M |
| Total Depreciation and Amortization | 1.32M | 1.05M | 642.00K | 793.00K | 663.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.90M | 5.74M | 5.14M | 4.47M | 7.12M |
| Change in Net Operating Assets | -3.51M | -1.12M | -8.83M | -12.71M | -4.79M |
| Cash from Operations | -24.79M | -18.94M | -28.34M | -35.93M | -25.17M |
| Capital Expenditure | -8.72M | -5.78M | -5.37M | -5.34M | -866.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.72M | -5.78M | -5.37M | -5.34M | -866.00K |
| Total Debt Issued | -- | -- | -- | -- | 51.20M |
| Total Debt Repaid | -- | -- | -- | -- | -50.00M |
| Issuance of Common Stock | 2.87M | 162.12M | 2.43M | 380.00K | 1.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -4.00M |
| Cash from Financing | 2.87M | 162.12M | 2.43M | 380.00K | -1.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.64M | 137.40M | -31.28M | -40.89M | -27.36M |